ArticleFrontiers in pediatrics2026
Clinical outcomes in pediatric acute lymphoblastic leukemia: a retrospective cohort study from a tertiary center in Indonesia.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, accounting for approximately 80% of childhood acute leukemia cases. Despite substantial improvements in survival in high-income countries, outcomes in Indonesia remain suboptimal. Methods: This retrospective cohort study analyzed medical records of pediatric ALL patients treated at Dr. Mohammad Hoesin General Hospital, Palembang, from 2019 to 2023 to describe demographic, clinical, laboratory, and immunophenotypic characteristics and their association with overall survival. Results: Most patients were aged 1-10 years, male, and had normal nutritional status, with leukocyte counts <50,000/µL, thrombocytopenia, and no central nervous system involvement or mediastinal mass. B-lineage ALL predominated. Univariate survival analysis showed that age at diagnosis, nutritional status, mediastinal mass, leukocyte count, and risk stratification were significantly associated with overall survival, whereas immunophenotypic classification was not. Multivariate Cox regression identified age >10 years and poor nutritional status as independent predictors of poorer overall survival. Conclusion: These findings underscore the importance of early diagnosis and nutritional optimization to improve overall survival in pediatric ALL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.